Introduction
Hepatocellular carcinoma (HCC) is the third highest cause of mortality among all malignant tumors in the world. [1] [2] [3] Accurate diagnosis of HCC is crucial for optimizing treatment outcomes. 4 Diagnostic imaging technology, including ultrasound (US), computed tomography (CT), and positron emission computed tomography (PET), has become an active area of research and has been playing a key role in HCC diagnosis. [5] [6] [7] [8] Despite the diversity of bio-imaging techniques, several technical problems have yet to be solved, such as weak penetrability, low sensitivity, and insufficient spatial or temporal resolution, which hinder accurate diagnosis. 9, 10 Magnetic resonance imaging (MRI), with the advantages of noninvasive, multiparametric imaging and deep soft-tissue penetration, has become a powerful technique in cancer diagnosis. [11] [12] [13] Superparamagnetic iron oxide nanoparticles (NPs), a kind of powerful T2 contrast agent, are commonly used as magnetic vectors for MRI. Compared with gadolinium-based MRI contrast agents, including Magnevist ® (Gd-DTPA; Bayer Schering Pharma, Berlin, Germany) and Multihance ® (Gd-BOPTA; Bracco Diagnostics Inc., Princeton, NJ, USA), 14, 15 superparamagnetic iron oxide NPs have been intensively investigated as promising MRI probes because of their biocompatibility and safety profiles as well as suitable magnetic properties. [16] [17] [18] However, limitations such as low sensitivity have hindered the further application of MRI as the sole methodology in the diagnosis
Dovepress

2034
liang et al of HCC. [19] [20] [21] To overcome the shortcomings, multimodal imaging techniques combining complementary advantages of different imaging modalities have attracted significant attention. For example, CT/MR imaging is obtained by multimodal contrast agents based on Au and Fe 3 O 4 NPs to get more information of tumor localization, [22] [23] [24] while Au shell coated on the surface of Fe 3 O 4 NPs may also result in the reduction of MRI contrast signal. Moreover, PET/MRI has been used clinically worldwide because PET is highly concentration-sensitive while supplying low resolution and MRI provides anatomic information in submillimeter range with high resolution. 25, 26 Nevertheless, there are drawbacks; for instance, PET-MRI systems can suffer from unwanted interference between PET radiofrequencies and MRI magnetic fields.
Lately, along with the development of versatile fluorescent probes, especially near-infrared fluorescent probes, fluorescence imaging (FI) is becoming a promising tool to noninvasively resolve three-dimensional spatial distribution of fluorescent probes associated with molecular and cellular function. 27 Compared with other modalities, FI has several advantages, such as high sensitivity and specificity, operational simplicity, safety, and cost effectiveness, 28, 29 though limited depth perception. Thus, the combination of FI and MRI into a single nanostructure can offer robust imaging capabilities with the prospect of improved detection accuracy in clinical diagnosis. [29] [30] [31] To date, there is no commercial probe available in the market with MRI/FI dual-modal capabilities. In the present study, a multifunctional nanoplatform consist of galactosyl conjugated P 123 (Gal-P 123 )-modified IR783-Fe 3 O 4 (GPC@IR783-Fe 3 O 4 ) NPs was designed for dual-modal fluorescence and MR imaging of tumors. Fe 3 O 4 NPs were first labeled with IR-783 and then encapsulated in a lipid shell modified with hepatocellular carcinomatargeting polymer (Figure 1 ). Gal-P 123 was an HCC targeting material that was synthesized in our previous study. 32, 33 We hypothesize that Gal-P 123 conjugated with fluorescence-MRI nanoparticle systems may enhance the resolution of targeting sites and supply reliable covalidation diagnosis of HCC. The formed GPC@IR783-Fe 3 O 4 NPs were characterized, and then their cytocompatibility and in vivo biocompatibility were evaluated. To demonstrate the diagnostic potential of these NPs, specific cellular uptake was examined by flow cytometry and confocal laser scanning microscopy (CLSM), and in addition, dual-modal fluorescence-MR imaging of tumor was evaluated in Huh-7 tumor-bearing mice. animals and tumor xenograft models BALB/c nude mice (18-22 g, ♂) were provided by Shanghai Laboratory Animal Center, CAS. These animals were maintained under the animal care facility for acclimatization 34 Particles were collected and stored in PBS. Then, Gal-P 123 modified IR783-Fe 3 O 4 (GPC@ IR783-Fe 3 O 4 ) NPs were prepared by the thin-film dispersion method. PC, Gal-P 123 , and Chol (Gal-P 123 , 3.5 mg; PC, 5.5 mg; and Chol, 0.9 mg) were dissolved in chloroform in a round flask and evaporated to form a thin film under reduced pressure. Finally, the film was dispersed in IR-783-labeled Fe 3 O 4 NPs solution by gentle shaking at 37°C. This was followed by extruding four times through a 200 nm-pore polycarbonate membrane with an Avestin Emulsi Flex-C5 high pressure extruder (Ottawa, ON, Canada). PC modified IR783-Fe 3 O 4 (PC@IR783-Fe 3 O 4 ) NPs were formulated using the same method, except that the shell consisted of PC and Chol (PC, 9 mg; Chol, 0.9 mg). Gel-filtration chromatography was used for purification of PC@IR783-Fe 3 O 4 and GPC@IR783-Fe 3 O 4 from the excess of uncoated lipid.
Materials and methods Materials
characterization of Fe 3 O 4 NPs
The mean diameter and zeta potential of NPs in water were monitored by a Malvern Zetasizer Nano ZS analyzer (Malvern Instruments Ltd., Worcestershire, UK). 
Vibrating sample magnetometry (VsM) analysis
The magnetic properties of IR783-Fe 3 O 4 , PC@IR783-Fe 3 O 4 , and GPC@IR783-Fe 3 O 4 NPs were studied by using a VSM (Lake Shore Cryotronics, Westerville, OH, USA) at room temperature up to H =2T. Saturation magnetization was obtained by extrapolating to an infinite field the experimental results obtained in the high field range, where magnetization linearly increases with 1/H.
In vitro cytotoxicity study
The cell viability of IR-783-labeled iron oxide NPs on normal cell lines (LO2) was evaluated by using the standard MTT assay. LO2 cells (1×10 4 cells per well) were seeded in 96-well culture plates. After being cultured for 24 h, the cells were exposed to NPs with different concentrations for 24 h, after which 20 μL 5 mg/mL MTT (Sigma) solution was added. After 4 h of incubation, the medium was removed, and the cells were mixed with 150 μL of dimethyl sulfoxide. The absorbance of solutions was measured at a test wavelength of 490 nm by a microplate reader. Relative cell viability (R) was calculated as follows.
100 , where A test and A control were the absorbance of the cells treated with the test solutions and blank culture medium (FBS free) as a negative control, respectively.
cellular uptake of rITc-labeled Fe 3 O 4 NPs
Huh-7 cells (1×10 5 cells per well) were seeded in 24-well plates and cultured at 37°C for 24 h. The medium was replaced with fresh medium; meanwhile, RITC-labeled iron oxide NPs (100 μg/mL Fe/well) were added in the culture medium and incubated for 2 h at 37°C. Next, the cells were washed three times with ice-cold PBS and fixed with 4% paraformaldehyde for 15 min, and then washed three times with PBS. The nuclei were stained with 4′,6-diamidino-2-phenylindole for 10 min and observed by CLSM.
Flow cytometry was also used to evaluate the cellular uptake of RITC-labeled Fe 3 O 4 NPs (100 μg/mL Fe/well). Huh-7 cells were seeded at 1×10 5 cells per well for 24 h at 37°C prior to the study. The cells were then incubated in medium containing RITC-labeled NPs. After 2 h of incubation, the cells were washed with PBS three times, harvested by trypsinization, and collected in PBS to quantify fluorescent signals of RITC. Tumors as well as internal organs (heart, liver, spleen, lung, and kidney) were removed at 6 h postinjection and analyzed directly on the fluorescence imager.
In vivo bio-fluorescence imaging
In vivo MrI imaging
To investigate the iron oxide NPs' targeting potential and the MRI sensitivity of GPC@IR783-Fe 3 O 4 in vivo, MRI was performed with a 7.0T experimental MRI instrument (BioSpec 70/20 USR; Bruker, Billerica, MA, USA) on Huh-7 tumor-bearing mice. Iron oxide NPs were injected intravenously at a dose of 2 mg Fe per kg of mouse body weight, and the coronal MRI images were scanned at preinjection and 6 h postinjection (n=3 per group). Imaging parameters were set as follows: repetition time (TR)/echo time (TE) =2,800/34 ms, field of view =4×4 cm, and slice thickness =1 mm. The signal intensity (SI) of the tumors was determined using a region of interest within the defined tumor area and normalized to the SI of the muscle tissue. Relative signal enhancement (RSE) of tumor was calculated using the following equation: SI pre and SI post were measured at preinjection and 6 h after injection.
histology analysis
Two hundred microliters of normal saline containing 0.8 mg of IR-783-labeled iron oxide NPs was injected intravenously into the nude mice through the tail vein. The mice were anatomized after 15 days. The paraffin sections of the heart, liver, spleen, lung, and kidney were stained with hematoxylin and eosin (H&E) and visualized by the inverted fluorescence microscope.
statistical analysis
Statistical analysis of all data was performed via Student's t-test or one-way analysis of variance (ANOVA) and expressed as mean ± SD. P-values less than 0.05 were considered statistically significant. NPs exhibited a core-shell structure, indicating the successful coating of a lipid layer on the surface ( Figure 2B ). As shown in Table S1 To evaluate the in vitro specific cellular uptake of Gal-P 123 -conjugated RITC-Fe 3 O 4 NPs, cell imaging was performed using CLSM with Huh-7 cells, which have a high expression of asialoglycoprotein (ASGP) receptors. As shown in Figure 4A Figure 4B ). These results implied that the lipid layer might play an important role in increasing the affinity of lipid-coated NPs to the cell membrane, and therefore promoted cellular uptake through a mechanism described as contact-facilitated delivery. 39 As it has been reported, ASGP receptors exhibit high affinity of Gal-modified NPs via receptor-mediated endocytosis. 40 Results from the flow cytometry assay were consistent with those of the CLSM imaging assay ( Figure S1 ), confirming that Gal-P 123 -conjugated Fe 3 O 4 NPs displayed excellent specific uptake by Huh-7 cells. Figures S2 and 5B) . The powerful tumor-targeting ability of GPC@IR783-Fe 3 O 4 could be attributed to the specific affinity of Gal-P 123 with ASGPR overexpressed by hepatocellular carcinoma cells. As reported previously, ASGPR is an integral membrane protein specifically expressed in hepatocytes and overexpressed in tumor hepatocytes. Especially in tumoral hepatocytes, this overexpressed receptor loses its polarized distribution and specifically binds terminal residues of galactose, allowing the Gal-modified polymer to target to these cells. 40, 41 In vivo MrI imaging application
Results and discussion
In vivo bio-fluorescence imaging and tumor targeting
The distribution of GPC@IR783-Fe 3 O 4 in mouse tumor tissues was also assessed by T 2 -weighted MR imaging. Sequential coronal images of 1 mm thickness were obtained before injection and 6 h after injection of three types of Fe 3 O 4 NPs. Figure 6A illustrates that all NPs caused contrast enhancement in the tumor sites after intravenous administration. Moreover, the injection of GPC@IR783-Fe 3 O 4 resulted in higher MR contrast in the tumor sites than 90% even at a high concentration of 500 μg/mL. These results demonstrated that GPC@IR783-Fe 3 O 4 NPs possess excellent cell compatibility and low cytotoxicity. To further investigate the potential toxicity in vivo, GPC@IR783-Fe 3 O 4 NPs were injected into the nude mice at a dose of 4 mg Fe per kg of mouse body weight. For more than 15 days, these nude mice didn't behave abnormally compared with healthy nude mice without administration. Histological sections of their five major organs were stained with H&E. No appreciable inflammatory response, cell degeneration, necrosis, or embolism was detected between the treated organs and the normal organs, proving that GPC@IR783-Fe 3 O 4 caused no harm to the mice ( Figure 7B ). These results effectively provide evidence that GPC@IR783-Fe 3 O 4 should be safe for biomedical imaging. Notes: Mean ± sD; n=3. Abbreviations: Pc, phosphatidylcholine; gPc, galactosyl conjugated pluronic P 123 /phosphatidylcholine; sD, standard deviation; NPs, nanoparticles.
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. This journal is indexed on PubMed Central, MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition, EMBase, Scopus and the Elsevier Bibliographic databases. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.
International 
In vivo bio-fluorescence imaging and tumor targeting
Tumor-bearing mice were injected via the tail vein at a dose of 2 mg Fe per kg of mouse body weight. Tumors as well as internal organs (heart, liver, spleen, lung, and kidney) were removed at 6 h postinjection and analyzed directly on the fluorescent imager. Visualization was observed at excitation of 730 nm and emission of 790 nm. Living Image software was used to calculate the fluorescence intensity of the organs.
